NVO vs UNH
NVO: A leading global healthcare company with a heritage in diabetes, pioneering scientific breakthroughs to defeat serious chronic diseases through innovative medicines and expanded access. UNH: UnitedHealth Group is a diversified health care company operating through two complementary businesses—Optum (healthcare services, pharmacy, data/analytics) and UnitedHealthcare (health insurance plans)—that serve patients, payers, providers, and employers across the entire care continuum.
Side-by-side fundamentals
| Metric | NVO | UNH | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $48.18 | $423.56 | |
| Market cap as of 2026-07-25 | $217.3B | $381.5B | |
| P/E as of 2026-07-25 | 11.64 | 27.01 | NVO lower |
| PEG as of 2026-07-25 | 16.16 | 4.05 | UNH lower |
| Net margin as of 2026-07-25 | +37.2% | +3.1% | NVO higher |
| Gross margin as of 2026-07-25 | +81.8% | n/a | |
| Operating margin as of 2026-07-25 | +45.3% | +4.7% | NVO higher |
| ROE as of 2026-07-25 | +66.4% | +14.4% | NVO higher |
| ROA as of 2026-07-25 | +23.3% | +4.5% | NVO higher |
| Debt / equity as of 2026-07-25 | 0.72 | 0.70 | UNH lower |
| Revenue growth (YoY) as of 2026-07-25 | +8.1% | +6.5% | NVO higher |
| Revenue CAGR (3y) SEC XBRL | n/a | +11.4% | |
| Dividend yield as of 2026-07-25 | +3.7% | +2.2% | NVO higher |
| Dividend streak (yrs) SEC XBRL | n/a | 1 | |
| Beta as of 2026-07-25 | 1.85 | 0.63 | |
| 1-year return as of 2026-07-23 close | -22.9% | +51.0% | UNH higher |
Fundamentals: Finnhub, as of 2026-07-25. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.